MSI rakes in $30 mln from Quark Venture
Vancouver, British Columbia-based MSI Methylation Sciences Inc, a clinical-stage pharmaceutical company that develops new treatments based on molecules, has raised $30 million in funding. The backer was Quark Venture Inc.
7 October 2016•1 min read
